OSCR - NYSE
Oscar Health, Inc.
$20.50
-0.44%Oscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
At a Glance
Live Snapshotoscr
Cash at Beginning of Period
Last Annual Value
1.55B
3-Year CAGR
11%
5-Year CAGR
34%
10-Year CAGR
15%
Oscar Health, Inc. Competitors Analysis of Cash at Beginning of Period
| Company | Cash at Beginning of Period | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
Oscar Health, Inc. NYSE:OSCR | 1.55B | -0.6% | 13.0% | N/A | |
 Option Care Health, Inc. NASDAQ:OPCH | 412.56M | 11.9% | 33.0% | 38.8% | |
 Arcellx, Inc. NASDAQ:ACLX | 108.31M | 17.5% | 18.3% | N/A | |
 TransMedics Group, Inc. NASDAQ:TMDX | 337.15M | 18.7% | 68.1% | 41.4% | |
 Kymera Therapeutics, Inc. NASDAQ:KYMR | 126.05M | 19.1% | 31.1% | N/A | |
 Hinge Health, Inc. NYSE:HNGE | 302.59M | -0.0% | N/A | N/A | |
 NewAmsterdam Pharma Company N.V. NASDAQ:NAMS | 771.74M | 18.2% | 140.2% | N/A | |
 Immunovant, Inc. NASDAQ:IMVT | 713.97M | 13.1% | 48.0% | N/A | |
 Viking Therapeutics, Inc. NASDAQ:VKTX | 26.68M | -10.0% | -1.7% | 42.6% | |
 Akero Therapeutics, Inc. NASDAQ:AKRO | 234.21M | -2.1% | 4.6% | N/A | |
 Alignment Healthcare, Inc. NASDAQ:ALHC | 434.94M | 1.9% | 15.9% | N/A |
Oscar Health, Inc. Fair Value Envelope
Related Guides
Continue your OSCR research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.